BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31508837)

  • 1. Intranasal inoculation of recombinant DNA vaccine ABA392 against haemorrhagic septicaemia disease.
    Kang TL; Chelliah S; Velappan RD; Kabir N; Mohamad J; Nor Rashid N; Ismail S
    Lett Appl Microbiol; 2019 Nov; 69(5):366-372. PubMed ID: 31508837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ABA392/pET30a protein of Pasteurella multocida provoked mucosal immunity against HS disease in a rat model.
    Kang TL; Velappan RD; Kabir N; Mohamad J; Rashid NN; Ismail S
    Microb Pathog; 2019 Mar; 128():90-96. PubMed ID: 30584901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.
    Muangthai K; Tankaew P; Varinrak T; Uthi R; Rojanasthien S; Sawada T; Sthitmatee N
    J Vet Med Sci; 2018 Jan; 80(1):68-76. PubMed ID: 29109353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential DNA Vaccine for Haemorrhagic Septiceamia Disease.
    Chelliah S; Velappan RD; Lim KT; Swee CWK; Nor Rashid N; Rothan HA; Kabir N; Ismail S
    Mol Biotechnol; 2020 May; 62(5):289-296. PubMed ID: 32185600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunisation of cattle and buffaloes with live haemorrhagic septicaemia vaccine.
    Carter GR; Myint A; Van Khar R; Khin A
    Vet Rec; 1991 Aug; 129(9):203. PubMed ID: 1957476
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety, efficacy and cross-protectivity of a live intranasal aerosol haemorrhagic septicaemia vaccine.
    Myint A; Jones TO; Nyunt HH
    Vet Rec; 2005 Jan; 156(2):41-5. PubMed ID: 15675522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of
    Fegan JE; Waeckerlin RC; Tesfaw L; Islam EA; Deresse G; Dufera D; Assefa E; Woldemedhin W; Legesse A; Akalu M; Bayissa B; Nguyen QH; Ng D; Ahn SK; Schryvers AB; Tefera TA; Moraes TF; Gray-Owen SD
    Front Immunol; 2024; 15():1392681. PubMed ID: 38835751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity provided by haemorrhagic septicaemia-subunit vaccine in ruminants.
    Maslog FS
    Dev Biol Stand; 1998; 92():301-7. PubMed ID: 9554285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific antibodies of Pasteurella multocida in newborn calves of vaccinated dams.
    el-Eragi AM; Mukhtar MM; Babiker SH
    Trop Anim Health Prod; 2001 Jul; 33(4):275-83. PubMed ID: 11474861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intranasal vaccination of field buffaloes against haemorrhagic septicaemia with a live gdhA derivative Pasteurella multocida B:2.
    Rafidah O; Zamri-Saad M; Shahirudin S; Nasip E
    Vet Rec; 2012 Aug; 171(7):175. PubMed ID: 22815208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection, humoral and cell-mediated immune responses in calves immunized with multiple emulsion haemorrhagic septicaemia vaccine.
    Verma R; Jaiswal TN
    Vaccine; 1997 Aug; 15(11):1254-60. PubMed ID: 9286053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of 87 kDa outer membrane protein gene of Pasteurella multocida P52.
    Chaudhuri P; Goswami PP
    Res Vet Sci; 2001 Jun; 70(3):255-6. PubMed ID: 11676623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant transferrin binding protein A (rTbpA) fragments of Pasteurella multocida serogroup B:2 provide variable protection following homologous challenge in mouse model.
    Shivachandra SB; Yogisharadhya R; Kumar A; Mohanty NN; Nagaleekar VK
    Res Vet Sci; 2015 Feb; 98():1-6. PubMed ID: 25544697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live haemorrhagic septicaemia vaccine for cattle and buffaloes.
    Jones TO; Myint A; Carter GR
    Vet Rec; 2002 Jan; 150(4):120. PubMed ID: 11838999
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between Pasteurella multocida B:2 and its derivatives with bovine aortic endothelial cell (BAEC).
    Kamal NM; Zamri-Saad M; Masarudin MJ; Othman S
    BMC Vet Res; 2017 Jun; 13(1):186. PubMed ID: 28629460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse model of haemorrhagic septicaemia: dissemination and multiplication of Pasteurella multocida B:2 in vital organs after intranasal and subcutaneous challenge in mice.
    Kharb S; Charan S
    Vet Res Commun; 2013 Mar; 37(1):59-63. PubMed ID: 23239257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.
    Hodgson JC; Finucane A; Dagleish MP; Ataei S; Parton R; Coote JG
    Infect Immun; 2005 Mar; 73(3):1475-81. PubMed ID: 15731045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bovine antibody responses to haemorrhagic septicaemia vaccine.
    Johnson RB; Dawkins HJ; Spencer TL; Saharee AA; Bahaman AR; Ramdani ; Patten BE
    Res Vet Sci; 1989 Sep; 47(2):277-9. PubMed ID: 2508206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunization provides better protection than subcutaneous immunization against Pasteurella multocida (B:2) in mice preimmunized with the outer membrane proteins.
    Kharb S; Charan S
    Vet Res Commun; 2011 Oct; 35(7):457-61. PubMed ID: 21633791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of haemorrhagic septicaemia alum-precipitated vaccine.
    Myint A; Jones TO
    Vet Rec; 2007 Feb; 160(5):172. PubMed ID: 17277309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.